Atypical Chronic Myeloid Leukemia Clinical Trials

8 clinical trials for Atypical Chronic Myeloid Leukemia across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant — RECRUITING · PHASE1
• Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia — RECRUITING · PHASE1
• Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor — RECRUITING · PHASE2
• Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia — NOT_YET_RECRUITING · PHASE2
• Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders — ACTIVE_NOT_RECRUITING · PHASE2
• Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer — COMPLETED · PHASE2
• Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) — WITHDRAWN · PHASE1

Refine this search